Seoul Semiconductor Applies Violeds Disinfection Technology to Luxury Sedan Genesis G90
UV-C disinfection technology solution, Violeds, developed by Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a globally recognized optical semiconductor manufacturer, is installed in the console boxes of Genesis, a global luxury vehicle brand, with the disinfection technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005088/en/
[Photo 1] Violeds UV-C LEDs are applied inside of the armrest console box of Genesis G90 (Graphic: Business Wire)
Luxury sedan Genesis G90 was officially launched for the market in the first half of 2022. The armrest console box in the back of G90 is equipped with UV-C LED lamps to disinfect passengers’ belongings in preparation for the era of COVID-19. Seoul Semiconductor’s violeds technology is applied to these UV-C LED lamps. Depending on its models, 6 to 12 LED lamps are installed, eliminating up to 99.9% of harmful germs (E.coli, staphylococcus aureus, and pneumobacilli) in personal possessions within 10 minutes after the lid is closed.
* The test results offered by Hyundai Motor Company and validated by Intertek, a global testing and certification agency, are subject to change depending on real environments
Violeds is a patented solution developed and massively applied for the first time in the world by Seoul Viosys, Seoul Semiconductor’s subsidiary. It prevents the growth of germs and bacteria with UV LEDs. According to 2021 data from Omdia, a market research agency, Seoul Viosys ranks 1st in the world in UV LED technology.
Seoul Viosys has successfully developed air sterilization solutions, as well as violeds-based surface disinfection systems. In August 2021, the company held a press conference to release its solution to prevent the spread of the delta variant, which is able to remove 99% of indoor airborne viruses. Based on the test results, it demonstrated the process of disinfecting auto air conditioning systems at CES 2022, making its technological prowess be globally recognized.
“We are very pleased to supply violeds-based UVC LEDs to global luxury brand Genesis G90. Operating our own auto air and surface sterilization lab, we have done our utmost to further develop UV LED disinfection technology. As a result, violeds technology will take the lead in expanding vehicle indoor healthcare markets in the world,” said a Seoul Semiconductor official.
He added, “acquiring the AEC-Q102 certification, the automotive LED reliability standard, violeds technology will become an optimized solution for auto healthcare projects required by clients.”
Based on more than 30 years of R&D experiences in optical semiconductor, Seoul Semiconductor has successfully established a product portfolio with all wavelength bands (200 ~ 1,600nm) from UV to visible rays and IR (VCSEL) applicable to auto solutions, holding 18,000 tech patents and thereby maintaining technological superiority in global markets.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Seoul Semiconductor Co., Ltd.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ONWARD Announces Participation at Upcoming Events in October29.9.2022 07:30:00 CEST | Press release
ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced that management will participate in the following upcoming events in October: Investors’ Day Geneva October 5, 2022 Geneva, Switzerland Dave Marver, CEO, will give a company presentation. The 3rd Annual Reeve Summit October 13-14, 2022 Washington, DC USA Dave Marver will participate in a keynote session, The Power of Partnership to Speed Cures to Market, with Marco Baptista, Chief Scientific Officer, Christopher & Dana Reeve Foundation. Oppenheimer Healthcare Showcase October 18, 2022 Palo Alto, CA USA Lara Smith Weber, CFO, will give a company presentation and participate in 1:1 meetings. VFB Soirées (Flemish Federation of Investors) October 27, 2022 Virtual event at 19:30 CET Dave Marver, CEO, will give a company presentation. Information on upcoming conferences is available in the investor
Mavenir Launches 5G Small Cell for High-Capacity In-building Standalone Coverage29.9.2022 07:30:00 CEST | Press release
Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced the unveiling of its latest 5G small cell at the upcoming India Mobile Congress (IMC) event in Pragati Maidan, New Delhi. Mavenir’s 5G small cell (E511), is a globally applicable product, with the flexibility to support both distributed and centralized ORAN architectures. Building on an established install base of over 2 million small cell units deployed globally, the 5G small cell forms part of an expanding small cell portfolio, that leverages Mavenir’s end-to-end RAN solution including a common Management System and CU. This flexibility, coupled with zero touch provisioning - ease of deployment, cost-effective, high-capacity solution is ideal for a variety of deployment use cases, including Enterprises such as office, retail, warehousing, manufacturing, and public spaces. Puneet Sethi, Mavenir’s SVP and GM
The LYCRA Company Announces Collaboration With Qore ® to Use QIRA ® for Next Generation Bio-derived LYCRA ® Fiber at Scale29.9.2022 02:00:00 CEST | Press release
The LYCRA Company,a global leader in developing innovative fiber and technology solutions for the textile and apparel industry, today announced it has entered into an agreement with Qore® to enable the world’s first large-scale commercial production of bio-derived spandex using QIRA®, the next generation 1,4-butanediol (BDO), as one of its main ingredients. This will result in 70% of the LYCRA® fiber content being derived from annually renewable feedstock. This change could potentially reduce the carbon footprint of LYCRA® fiber by up to 44%* versus equivalent product made from fossil-based resources, while maintaining the same high-quality performance parameters of traditional LYCRA® fiber. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220928005020/en/ The LYCRA Company signs an agreement with Qore® LLC to enable large-scale production of bio-derived spandex. Pictured – Julien Born, CEO of The LYCRA Company (left), and Jon
Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation ™28.9.2022 22:30:00 CEST | Press release
Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, published in the journal of the International Neuromodulation Society, Neuromodulation,further establish the efficacy and safety of ReActiv8 Restorative Neurostimulation, including compelling long-term durability and improvement over time on key outcome measures in the treatment of intractable chronic low back pain. The three-year data show improvements over results from the patients’ one-year and two-year visits on virtually all key efficacy measures. Of note: Outcome measure 1-year result (N = 176) 2-year result (N = 156) 3-year result (N = 133) Patients reporting pain intensity (Visual Analog Scale (VAS) score) reduced by 50% or more from baseline 64% 71% 77% Patients reporting a greater than 20-point reduction in Oswestry Disability Index 57% 61% 63% Patients reporting VAS score < 2.5 52% 65% 67% Patients taking opioids at basel
New Study From Egon Zehnder and Kearney Debunks the Myth of a Workplace Generational Divide28.9.2022 16:00:00 CEST | Press release
Egon Zehnder, the world’s preeminent leadership advisory firm, in partnership with Kearney, a leading global management consulting firm, today released findings from a new survey with over 8,000 respondents from eight different countries dismissing the myth of a generation divide in the workplace and showing that despite what is often believed, Gen Z, Millennials, Gen X and Boomers are more alike than different when it comes to workplace matters. The survey, titled “Different Generations, Same Ideals: What Workers of All Ages Value in their Jobs,” analyzed the similarities and differences among generations and found that they share more commonalities, especially when it comes to personal well-being, work-life balance, and desired traits from leadership. The most notable difference between the generations is how each group defines and plans to achieve their career desires. Key Findings from the survey include: Personal well-being, stability, and work-life balance matter more than money
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom